CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Bylaws or fiscal year change
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Executive or director change · Shareholder vote results
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy CSO/CMO bought 770 shares at $6.50 ($5,005)
- 4 Open-market buy Chief Financial Officer bought 2,500 shares at $6.50 ($16,250)
- 4 Open-market buy President & CEO bought 200,000 shares at $6.50 ($1,300,000)
- 4 Open-market buy Director bought 45,769 shares at $6.50 ($297,499)
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement · Code of ethics change
Page 36 of 50 · 1,000 filings